Sustained release poloxamer containing pharmaceutical compositions

Details for Australian Patent Application No. 2009215664 (hide)

Owner Allergan, Inc.

Inventors Hunt, Terrence J.

Agent Davies Collison Cave

Pub. Number AU-A-2009215664

PCT Pub. Number WO2009/105369

Priority 12/036,139 22.02.08 US

Filing date 11 February 2009

Wipo publication date 27 August 2009

International Classifications

A61K 38/48 (2006.01) Medicinal preparations containing peptides

A61K 9/08 (2006.01) Medicinal preparations characterised by special physical form - Solutions

A61K 47/34 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds

Event Publications

9 September 2010 PCT application entered the National Phase

  PCT publication WO2009/105369 Priority application(s): WO2009/105369

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009215667-Syngas conversion system using asymmetric membrane and anaerobic microorganism

2009215661-System and method for printing using variable-density white ink under-printed layer